Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04187053 · ClinicalTrials.gov registry record · Phase 4
Clinical and Microbiologic Outcomes of aPDT in the Non-surgical Treatment of Implant Inflammation
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 56
- Enrollment target
NCT04187053 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 56 participants.
The verdict
NCT04187053, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to compare clinical outcomes (change in bleeding sites (BOP) and probing depth reduction (PPD) after mechanical debridement of implant surfaces at sites exhibiting plaque induced inflammation with or without adjunctive antimicrobial photodynamic therapy (aPDT) and assess the microbiologic profile of plaque samples before and after treatment with or without aPDT samples.
Interventions
- DRUG Saline
- DRUG Methylene Blue
- PROCEDURE Conventional mechanical therapy
- DEVICE Light emitting laser
- DEVICE Non-light emitting laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2020-02-14 |
| Est. Completion | 2022-12-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04187053
The ClinicalTrials.gov registry entry for NCT04187053 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Saline is the first listed.
NCT04187053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04187053 about?
NCT04187053 is a clinical study titled "Clinical and Microbiologic Outcomes of aPDT in the Non-surgical Treatment of Implant Inflammation". The purpose of this study is to compare clinical outcomes (change in bleeding sites (BOP) and probing depth reduction (PPD) after mechanical debridement of implant surfaces at sites exhibiting plaque induced inflammation with or without adjunctive antimicrobial photodynamic therapy (aPDT) and assess...
What is the current status of trial NCT04187053?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2020-02-14. Estimated completion is 2022-12-06.
What interventions are being tested in trial NCT04187053?
The interventions under investigation include: Saline (DRUG), Methylene Blue (DRUG), Conventional mechanical therapy (PROCEDURE), Light emitting laser (DEVICE), Non-light emitting laser (DEVICE).
Who is sponsoring clinical trial NCT04187053?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.